₹0.06
(Market cap
₹14 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
1.6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
0 %
-
ROCE
0 %
-
Industry P/E
59.18
-
EV/EBITDA
13773.1
-
Debt to Equity
0
-
Book Value
₹--
-
EPS
₹0
-
Face value
1
-
Shares outstanding
100,000,000
10 Years Aggregate
CFO
₹-0.12 Cr
EBITDA
₹-0.14 Cr
Net Profit
₹0.08 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Safal Herbs
| 106.0 | 89.0 | 70.4 | -32.4 | -28.6 | -45.2 | -- |
|
BSE Sensex*
| -8.5 | 1.9 | 1.3 | -5.1 | 6.1 | 6.7 | 10.8 |
|
BSE Healthcare#
| 17.7 | 3.5 | 7.6 | 14.1 | 22.7 | 14.7 | 12.2 |
|
Company
|
2019
|
2018
|
2017
|
2016
|
2015
|
2014
|
|---|---|---|---|---|---|---|
|
Safal Herbs
| -42.2 | -64.2 | -35.4 | -50.0 | -77.9 | 59.5 |
|
BSE Sensex
| 14.4 | 5.9 | 27.9 | 1.9 | -5.0 | 29.9 |
|
BSE Healthcare
| -3.5 | -5.9 | 0.5 | -12.9 | 15.1 | 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Safal Herbs
|
1.4 | 13.8 | 0.3 | 0.0 | -25.3 | -- | -- | 1.6 |
| 26.9 | 15.3 | 6.6 | 0.6 | 14.1 | 4.2 | 27.8 | 1.4 | |
| 514.3 | 6,393.4 | 851.5 | 236.3 | 36.3 | 57.6 | 27 | 12.0 | |
| 181.0 | 235.2 | 135.7 | -26.4 | -17.0 | -320 | -- | -11.7 | |
| 21.0 | 36.1 | 49.3 | 0.6 | 1.4 | 3.6 | 59.2 | 2.1 | |
| 37.2 | 36.0 | 69.6 | 1.8 | 3.4 | 4.1 | 20.3 | 1.0 | |
| 135.7 | 214.3 | 200.7 | 17.1 | -- | 28.7 | 12.5 | 3.2 | |
| 106.0 | 68.2 | 79.7 | 3.5 | 7.0 | 14.2 | 19.5 | 2.6 | |
| 184.8 | 194.2 | 89.9 | 7.2 | -- | 13.7 | 21.6 | 3.1 | |
| 29.9 | 28.1 | 71.8 | 2.8 | -- | 18.2 | 11.3 | 1.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Safal Herbs
Manufacture of ayurvedic' or unani' pharmaceutical preparation
-
Incorporated
1994
-
Chairman
--
-
Managing Director
Arushi Nigam
-
Headquarters
Delhi, Delhi
-
Website
--
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Safal Herbs
What is the current share price of Safal Herbs Ltd Today?
The share price of Safal Herbs Ltd is ₹1.38 (BSE) as of 11-Mar-2020 IST. Safal Herbs Ltd has given a return of -28.59% in the last 3 years.
What is the current PB & PE ratio of Safal Herbs Ltd?
Since, TTM earnings of Safal Herbs Ltd is negative, P/E ratio is not available.
The P/B ratio of Safal Herbs Ltd is 1.57 times as on 11-Mar-2020, a 25 discount to its peers’ median range of 2.09 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2020 |
7,365.11 |
1.57 |
2019 |
0.00 |
1.99 |
2018 |
0.00 |
3.17 |
2017 |
2,707.14 |
4.28 |
2016 |
6,807.06 |
8.57 |
What is the 52 Week High and Low of Safal Herbs Ltd?
The 52-week high and low of Safal Herbs Ltd are Rs -- and Rs -- as of 27-Aug-2026.
What is the market cap of Safal Herbs Ltd?
Safal Herbs Ltd has a market capitalisation of ₹ 14 Cr as on 11-Mar-2020. As per SEBI classification, it is a company.
Should I invest in Safal Herbs Ltd?
Before investing in Safal Herbs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.